University of Pittsburgh Cancer Institute (UPCI)

Meeting Schedule

UPCI PRC/PRMS committee meeting dates and deadlines for submission for 2015 are as follows:

COMMITTEE A
3:30-5:00pm, 5 East Conference Room
Andrew Laman, MD (Chairman)

COMMITTEE B
2:00-3:30pm, 5 East Conference Room
Leonard Appleman, MD (Chairman)

Deadline Dates For Submission Meeting Dates Deadline Dates For Submission Meeting Dates
December 26, 2014 January 12, 2015 *North CR January 9, 2015 January 26, 2015
January 23, 2015 February 9, 2015 February 6, 2015 February 23, 2015
February 20, 2015 March 9, 2015 March 6, 2015 March 23, 2015
March 20, 2015 April 6, 2015 April 3, 2015 April 20, 2015
April 17, 2015 May 4, 2015 May 1, 2015 May 18, 2015
May 18, 2015 June 8, 2015 June 5, 2015 June 22, 2015
June 19, 2015 July 6, 2015 July 6, 2015 July 20, 2015
July 24, 2015 August 10, 2015 August 7, 2015 August 24, 2015
August 27, 2015 September 14, 2015 September 11, 2015 September 28, 2015
September 25, 2015 October 12, 2015 *North CR October 9, 2015 October 26, 2015
October 23, 2015 November 9, 2015 November 6, 2015 November 23, 2015
November 20, 2015 December 7, 2015 December 10, 2015 December 28, 2015

Deadlines for submission to the PRC/PRMS are approximately two weeks before the scheduled meeting date. Please note that any trials lacking the required documentation for review by EOB on the dates listed above may not be placed on the next meeting agenda.

Required documents are the following:

  1. A completed PRC/PRMS checklist/program director letter
  2. A copy of full protocol
  3. A sponsor or UPCI consent form
  4. Investigator drug brochure
  5. All trials must receive sign-off from the Disease Center Director and all investigator-initiated trials must be approved by a University of Pittsburgh Biostatistician prior to submission to the PRC/PRMS.

Documents can be emailed to Brandon Kaukus at kaukusbm@upmc.edu or call 412-623-3376 if you have any questions.

Note: Any studies with Chairman as PI should be sent to the opposite committee for review.